We are merging our research database onto peptx, we will continue to work on it but this will have tonnes of info.
you'll soon be able to chat directly in whatsapp with our agent who can guide you on the research, doses, protocols and much more.
We are more than just a peptide commerce site.
https://t.co/tnO4yLhBPy
Making sure you eat the right food and supplements especially in high calorie deficits is so overlooked.
Peptides got flashy but the fundamentals stay the same.
Hit high protein, lock in your micros, train hard and sleep well. That combo beats everything else even when the deficit is steep. Peptides help but they dont replace the basics. Without them you risk losing muscle and feeling like shit.
Keep it simple. Protein first, bloodwork if needed, smart supps like creatine and electrolytes.
Boring habits win long term!
#peptides #fitness #biohacking
I have still not done a single ad yet for my business, traffic seems to ramp high then drop. In this time we have made many improvements like our own trained AI agent to assist information on peptides and also pricing.
Some big improvements and some COAs to be added soon.
#peptides #peptx
Kill off Helicobacter, heal and strengthen your gut.
1. Biofilm disruption (NAC)
2. Sulforaphane
3. Optimizing vitamin D and zinc
4. Probiotics with known anti-H.
5. Immune modulation (TA-1)
6. BPC-157 (Orally)
Thank me later.
Helicobacter pylori is the only bacterium known to cause cancer. It is responsible for an estimated 89% of all gastric cancers and is linked to the development of 5.5% of all cases cancers worldwide.
We are merging our research database onto peptx, we will continue to work on it but this will have tonnes of info.
you'll soon be able to chat directly in whatsapp with our agent who can guide you on the research, doses, protocols and much more.
We are more than just a peptide commerce site.
https://t.co/tnO4yLhBPy
At first I was sold that GLP-1 orals would be massive But the results just aren’t the same.
Tirzepatide injections hit up to 21% weight loss at 72 weeks. Retatrutide delivered up to 24% at 48 weeks and up to 28% at 80 weeks.
Orals like orforglipron? Only up to 12% at 72 weeks. Injections are still best. man up and get over the needle fear.
🏥 HEALTH, FITNESS & BIOHACKING ROUNDUP — June 08, 2026
1️⃣ THREE STUDIES DEBUNK POPULAR HEALTH TRENDS
A physician breaking down three major studies that challenge mainstream wellness advice: isocaloric time-restricted eating showed no cardiometabolic benefit beyond eating less, NAD+ boosters like NMN work through gut microbes rather than direct mitochondrial support, and epigenetic "aging clocks" don't track actual metabolic improvements during weight loss. The key lesson is to measure the outcome you actually care about, not assume the mechanism delivers results.
@taggehealth
2️⃣ RETATRUTIDE SHOWS 30% BODY WEIGHT LOSS
Eli Lilly disclosed new data for its next-generation triple-agonist weight-loss drug retatrutide, demonstrating patients lost approximately 30% of their body weight over roughly two years of treatment. The data provides more details on safety and tolerability of the compound that could become the successor to current GLP-1 medications.
@statnews
3️⃣ GLP-1 DRUGS MAY REDUCE DRUG ADDICTION
Research suggests GLP-1 receptors sit in the brain's reward circuitry, meaning these drugs may act on craving itself. Among 81,617 veterans with pre-existing substance use disorders, three years of GLP-1 use was associated with 40% fewer overdoses and 50% fewer drug-related deaths — a signal that extends well beyond weight management.
@jeffreytaekman
4️⃣ MAYIM BIALIK SHARES GLP-1 SIDE EFFECT STORY
Big Bang Theory actress and neuroscientist Mayim Bialik publicly shared her "nightmare" experience with a GLP-1 medication, highlighting that these drugs aren't for everyone and can interact with other medications. Her story underscores the importance of individual response and the need for more diverse clinical data.
@WGNNews
5️⃣ DOCTORS PRESCRIBING UNAPPROVED RETATRUTIDE
CBS News investigators visited clinics advertising retatrutide in Los Angeles, only to find those promotions disappearing from websites during the investigation. Despite the FDA saying compounding the drug is illegal, some clinics continue to prescribe this unapproved weight-loss compound to patients.
@ByDanielGilbert
6️⃣ RETATRUTIDE CUTS LIVER FAT BY UP TO 82%
Phase 2 trial data shows retatrutide delivers dramatic reductions in liver fat associated with metabolic dysfunction: at 24 weeks, higher doses achieved 81-82% relative liver fat reduction, with sustained effects at 48 weeks. This positions the drug as potentially transformative for MASLD treatment alongside weight loss benefits.
@biotides
7️⃣ INJECTION GLP-1S OUTPERFORM ORAL VERSIONS
Comparison data shows injected GLP-1 drugs significantly outperform oral alternatives: tirzepatide injections hit up to 21% weight loss at 72 weeks, retatrutide delivered up to 24% at 48 weeks and 28% at 80 weeks, while oral options like orforglipron maxed out at just 12% at 72 weeks — injections remain king.
@TestAlchemistx
💭 The health landscape in 2026 is rapidly evolving beyond simple weight-loss narratives. GLP-1 medications are revealing surprising secondary benefits — from reducing substance addiction to lowering cancer risk — while new triple-agonists like retatrutide push weight-loss percentages into territory previously thought impossible. Yet the regulatory landscape hasn't caught up, with unapproved compounds flooding clinics before safety data is complete. Meanwhile, rigorous studies continue to challenge wellness dogma, reminding us that correlation isn't causation and the body's mechanisms are far more complex than any single supplement or fasting protocol.
Which of these health developments do you find most impactful — the addiction research or the new weight-loss drug data? 👇
#HealthTech #GLP1 #Retatrutide #WeightLoss #Biohacking #Longevity #HealthNews
At first I was sold that GLP-1 orals would be massive But the results just aren’t the same.
Tirzepatide injections hit up to 21% weight loss at 72 weeks. Retatrutide delivered up to 24% at 48 weeks and up to 28% at 80 weeks.
Orals like orforglipron? Only up to 12% at 72 weeks. Injections are still best. man up and get over the needle fear.
Retatrutide Key Results (June 6, 2026):
TRIUMPH-1 (80 weeks): 12 mg → 70.3 lbs (28.3%) average weight loss; 65.3% reached BMI <30; major improvements in knee osteoarthritis pain and obstructive sleep apnea.
TRANSCEND-T2D-1 (40 weeks): Up to 2.0% A1C reduction (46% reached normal A1C); up to 36.6 lbs (16.8%) weight loss.
Triple agonist with strong efficacy across obesity and its complications.